The multiple faces of autoimmune-mediated bone loss (Q37806610)

23 August 2017

title

The multiple faces of autoimmune-mediated bone loss (English)

1 reference

23 August 2017

1

Georg Schett

1 reference

23 August 2017

Jean-Pierre David

2

1 reference

23 August 2017

publication date

2 November 2010

1 reference

Nature Reviews Endocrinology

23 August 2017

published in

1 reference

23 August 2017

volume

6

1 reference

23 August 2017

issue

12

1 reference

23 August 2017

page(s)

698-706

1 reference

https://scigraph.springernature.com/pub.10.1038/nrendo.2010.190

23 August 2017

exact match

0 references

cites work

Stromal niches, plasma cell differentiation and survival.

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.190

Organization of immunological memory by bone marrow stroma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.190

Osteoimmunology and the effects of the immune system on bone

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.190

Osteoimmunology: interactions of the bone and immune system

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.190

Osteoimmunology: a view from the bone

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.190

Cytokines in the pathogenesis of rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.190

Transcriptional networks controlling skeletal development

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.190

Genetic control of bone formation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.190

Wnt and PPARgamma signaling in osteoblastogenesis and adipogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.190

Genetic regulation of osteoclast development and function

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.190

Osteoclast differentiation and activation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.190

Osteoclast-osteoblast communication

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.190

RANKL-RANK signaling in osteoclastogenesis and bone disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.190

Secreted frizzled-related protein-1 inhibits RANKL-dependent osteoclast formation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.190

Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.190

TRANCE (tumor necrosis factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.190

Treg cells suppress osteoclast formation: a new link between the immune system and bone

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.190

T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-γ

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.190

IL-4 abrogates osteoclastogenesis through STAT6-dependent inhibition of NF-kappaB

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.190

Interleukin-4 Reversibly Inhibits Osteoclastogenesis via Inhibition of NF-κB and Mitogen-activated Protein Kinase Signaling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.190

IL-4 suppresses osteoclast development and mature osteoclast function by a STAT6-dependent mechanism: irreversible inhibition of the differentiation program activated by RANKL

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.190

CTLA-4 directly inhibits osteoclast formation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.190

Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.190

Human CD4+CD25+ regulatory T cells inhibit the differentiation of osteoclasts from peripheral blood mononuclear cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.190

Osteoclastogenesis is enhanced by activated B cells but suppressed by activated CD8(+) T cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.190

Activated T lymphocytes suppress osteoclastogenesis by diverting early monocyte/macrophage progenitor lineage commitment towards dendritic cell differentiation through down-regulation of receptor activator of nuclear factor-kappaB and c-Fos.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.190

Increased bone density and resistance to ovariectomy-induced bone loss in FoxP3-transgenic mice based on impaired osteoclast differentiation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.190

B cells and T cells are critical for the preservation of bone homeostasis and attainment of peak bone mass in vivo

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.190

T cells potentiate PTH-induced cortical bone loss through CD40L signaling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.190

IFN-gamma stimulates osteoclast formation and bone loss in vivo via antigen-driven T cell activation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.190

Bone remodeling, energy metabolism, and the molecular clock

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.190

The sympathetic tone mediates leptin's inhibition of insulin secretion by modulating osteocalcin bioactivity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.190

The transcription factor ATF4 regulates glucose metabolism in mice through its expression in osteoblasts

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.190

Osteocalcin differentially regulates beta cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.190

Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.190

Leptin regulates bone formation via the sympathetic nervous system

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.190

The molecular clock mediates leptin-regulated bone formation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.190

Transcriptional regulation of neuronal genes and its effect on neural functions: transcriptional regulation of neuropeptide Y gene by leptin and its effect on feeding

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.190

Attenuation of the obesity syndrome of ob/ob mice by the loss of neuropeptide Y.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.190

Hypothalamic Y2 receptors regulate bone formation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.190

Novel role of Y1 receptors in the coordinated regulation of bone and energy homeostasis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.190

Neuropeptide Y knockout mice reveal a central role of NPY in the coordination of bone mass to body weight

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.190

Neuropeptide Y acts directly in the periphery on fat tissue and mediates stress-induced obesity and metabolic syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.190

Hypothalamic control of bone formation: distinct actions of leptin and y2 receptor pathways

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.190

Hypothalamic regulation of cortical bone mass: opposing activity of Y2 receptor and leptin pathways

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.190

Neuromedin U has a novel anorexigenic effect independent of the leptin signaling pathway.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.190

Central control of bone remodeling by neuromedin U.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.190

Leptin functions peripherally to regulate differentiation of mesenchymal progenitor cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.190

Critical role of the hypothalamic-pituitary-thyroid axis in bone

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.190

Cytokines and cytokine profiles in human autoimmune diseases and animal models of autoimmunity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.190

Distinct monocyte gene-expression profiles in autoimmune diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.190

Increased monocytic activity and biomarkers of inflammation in patients with type 1 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.190

An inflammatory gene-expression fingerprint in monocytes of autoimmune thyroid disease patients.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.190

Osteoporosis Associated with Neutralizing Autoantibodies against Osteoprotegerin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.190

Bone inflammation and altered gene expression with type I diabetes early onset

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.190

Immune regulation in psoriasis and psoriatic arthritis--recent developments

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.190

Psoriasis-like skin disease and arthritis caused by inducible epidermal deletion of Jun proteins

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.190

Shifting the imbalance from Th1/Th2 to Th17/treg: the changing rheumatoid arthritis paradigm

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.190

Th17 and regulatory T cells: rebalancing pro- and anti-inflammatory forces in autoimmune arthritis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.190

Regulatory T cells protect from local and systemic bone destruction in arthritis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.190

Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis

31 March 2020

2 references

https://api.crossref.org/works/10.1038%2FNRENDO.2010.190

31 March 2020

12 December 2020

Osteoprotegerin protects against generalized bone loss in tumor necrosis factor-transgenic mice

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.190

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.190

The role of inflammation in insulitis and beta-cell loss in type 1 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.190

Joint genetic susceptibility to type 1 diabetes and autoimmune thyroiditis: from epidemiology to mechanisms.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.190

The molecular genetics of type 1 diabetes: new genes and emerging mechanisms

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.190

Genetics of type 1A diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.190

Mediators and mechanisms of pancreatic beta-cell death in type 1 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.190

Diabetes Mellitus: Does it Affect Bone?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.190

Osteoporosis among patients with type 1 and type 2 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.190

Is insulin an anabolic agent in bone? Dissecting the diabetic bone for clues

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.190

Understanding the pathology and mechanisms of type I diabetic bone loss.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.190

Bone Loss and Increased Bone Adiposity in Spontaneous and Pharmacologically Induced Diabetic Mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.190

Type I diabetic bone phenotype is location but not gender dependent.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.190

Bone formation is impaired in a model of type 1 diabetes.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.190

Normal bone density obtained in the absence of insulin receptor expression in bone.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.190

Insulin receptor signaling in osteoblasts regulates postnatal bone acquisition and body composition

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.190

IGF-1 and IGF-binding proteins and bone mass, geometry, and strength: relation to metabolic control in adolescent girls with type 1 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.190

Central leptin gene therapy ameliorates diabetes type 1 and 2 through two independent hypothalamic relays; a benefit beyond weight and appetite regulation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.190

Leptin treatment induces loss of bone marrow adipocytes and increases bone formation in leptin-deficient ob/ob mice.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.190

Inhibition of PPARγ prevents type I diabetic bone marrow adiposity but not bone loss

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.190

Leptin treatment prevents type I diabetic marrow adiposity but not bone loss in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.190

Immunologic endocrine disorders.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.190

Fractures in patients with hyperthyroidism and hypothyroidism: a nationwide follow-up study in 16,249 patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.190

TSH Is a Negative Regulator of Skeletal Remodeling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.190

A lack of thyroid hormones rather than excess thyrotropin causes abnormal skeletal development in hypothyroidism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.190

Rheumatic diseases: the effects of inflammation on bone

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.190

Epidemiology of osteoporosis in rheumatic diseases.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.190

Review: vitamin D, immunity and lupus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.190

Bone status in juvenile systemic lupus erythematosus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.190

Bone and metabolism: a complex crosstalk

31 March 2020

1 reference

12 December 2020

TRANCE, a TNF family member, is differentially expressed on T cell subsets and induces cytokine production in dendritic cells

1 reference

12 December 2020

Reciprocal regulation of bone and energy metabolism.

1 reference

12 December 2020

Type 1 diabetes and autoimmune polyglandular syndrome: a clinical review.

1 reference

12 December 2020

Osteoporosis in patients with systemic lupus erythematosus.

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRENDO.2010.190

1 reference

23 August 2017

1 reference